Sens. Angela Alsobrooks and Ron Wyden are asking what steps the Department of Health and Human Services has taken to mitigate risks from the markets. Clinical trials have long been closely watched by patients and doctors hopeful for treatments to diseases. Now they have a new audience: people placing bets on prediction markets. It sounds like something out of a dystopian novel, but it’s true.